M4: Organisation
The document primarily addresses the organisation of the information to be presented in registration applications for new pharmaceuticals (including biotechnology-derived products).
ICH guideline M4 (R4) on common technical document. (CTD) for the registration of pharmaceuticals for human. use - organisation of CTD.
Having reached Step 4 of the ICH Process at the ICH Steering Committee meeting on November 8, 2000, this guideline is recommended for adoption to the three regulatory parties to ICH.
Module 4 Non-clinical study reports
Although it is recognised that the non-clinical data help to address the safety of the product, there are non-clinical studies (primary, secondary pharmacology stating the effects of the active substance on the different organs showing or not showing the intended efficacy.